Supplemental material
Postgraduate Medicine
Volume 132, 2020 - Issue 2
Open access
3,576
Views
21
CrossRef citations to date
0
Altmetric
Clinical Features - Health Outcomes
Real-world management of hyperkalemia with patiromer among United States Veterans
Csaba P. Kovesdya Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USACorrespondence[email protected]
View further author information
, View further author information
Elvira O. Gosmanovab Nephrology Section, Samuel S. Stratton VA Medical Center, Albany, NY, USA;c Division of Nephrology, Department of Medicine, Albany Medical College, Albany, NY, USAView further author information
, Steven D. Woodsd Managed Care and Health Outcomes, Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA, USAView further author information
, Jeanene J. Foglie Health Economics and Outcomes Research, Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA, USAView further author information
, Christopher G. Rowanf Pharmacoepidemiology, COHRDATA, Santa Monica, CA, USAView further author information
, Jared L. Hanseng Division of Epidemiology, Salt Lake City VA Medical Center (IDEAS), University of Utah, Salt Lake City, UT, USAView further author information
& Brian C. Sauerg Division of Epidemiology, Salt Lake City VA Medical Center (IDEAS), University of Utah, Salt Lake City, UT, USAView further author information
show all
Pages 176-183
|
Received 09 Sep 2019, Accepted 17 Dec 2019, Published online: 23 Jan 2020
Related Research Data
Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia:
Source:
SAGE Publications
Validity of Self-Reported Medication Use Compared With Pharmacy Records in a Cohort of Older Women: Findings From the Women's Health Initiative.
Source:
Oxford University Press (OUP)
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
Source:
Massachusetts Medical Society
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
Source:
Massachusetts Medical Society
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
Source:
Massachusetts Medical Society
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Source:
American Medical Association (AMA)
Patiromer for heart failure patients
Source:
Wiley
The AMETHYST-DN Randomized Clinical Trial
Source:
American Medical Association (AMA)
Managing Hyperkalemia Caused by Inhibitors of the Renin–Angiotensin–Aldosterone System
Source:
Massachusetts Medical Society
Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease
Source:
American College of Cardiology Foundation. Published by Elsevier Inc.
Compliance from Self-Reported versus Pharmacy Claims Data with Metered-Dose Inhalers
Source:
SAGE Publications
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.